OPPI launches ‘Bharat Ke Liye’ to reinforce commitment to improve health outcomes
This initiative encapsulates the essence of OPPI’s commitment towards enabling a healthier India
This initiative encapsulates the essence of OPPI’s commitment towards enabling a healthier India
ZYIL1 is a novel oral small molecule NLRP3 inhibitor which has demonstrated CSF penetration in non-human primates
KRIVIDA TRIVUS detects the specific virus causing a respiratory infection.
Lenalidomide capsules are a prescription medicine used in adults for the treatment of multiple myeloma.
The new powder flow tester can characterize powder flow properties, offering valuable insight for pharmaceutical processing and formulation
Natural Capsules Limited's shareholding will be reduced to 89.99%
lAIH strives to introduce appropriate interventions for nurturing an AMR innovation ecosystem in the country through cohesive efforts across the innovation pyramid
These patches can be used in settings where patients need close vital signs monitoring, including cardiac rhythm.
Submissions based on favorable MagnetisMM-3 trial results in patients with relapsed or refractory multiple myeloma
Subscribe To Our Newsletter & Stay Updated